NCT04209803View on ClinicalTrials.gov

N-Acetyl-Cysteine for Treatment of AGA in Men

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 1, 2018

Primary Completion Date

September 2, 2020

Study Completion Date

October 1, 2020

Conditions
Androgenetic Alopecia
Interventions
DRUG

Minoxidil 5% topically and oral NAC 600 mg

Topical 5% Minoxidil and N-Acetyl-Cysteine 600 mg orally

Trial Locations (1)

11711

dermatology clinics in Ain Shams University Hospital and Kafr El Sheik University Hospital., Cairo

All Listed Sponsors
collaborator

Ain Shams University

OTHER

lead

Kafrelsheikh University

OTHER

NCT04209803 - N-Acetyl-Cysteine for Treatment of AGA in Men | Biotech Hunter | Biotech Hunter